Top 25 ReViral investors
The most complete profiles first. Showing 25 of 25.
David BonitaVerified
Venture Capital, Private Equity Firm, Investor · United States
SeedSeries AHealth CareInvestment ManagementLife ScienceInformation Technology (IT)Portfolio: Edgewise Therapeutics, Syros Pharmaceuticals, Yisheng Biopharma, Evox Therapeutics and 93 more
Verified email available
Geoffrey HsuVerified
Venture Capital, Private Equity Firm, Investor · United States
SeedSeries AHealth CareInvestment ManagementLife ScienceInformation Technology (IT)Portfolio: Edgewise Therapeutics, Syros Pharmaceuticals, Yisheng Biopharma, Evox Therapeutics and 87 more
Verified email available
Olivier LitzkaVerified
Venture Capital, Private Equity Firm, Investor · Germany
Series BHealth CareWearablesHospitalsWellnessPortfolio: Genoa Pharmaceuticals, ENYO Pharma, OncoEthix, Noxxon Pharma and 83 more
Verified email available
Jonathan SilversteinVerified
Private Equity Firm · United States
Health CareLife ScienceInformation Technology (IT)MobilePortfolio: Edgewise Therapeutics, Syros Pharmaceuticals, Yisheng Biopharma, Evox Therapeutics and 87 more
Verified email available
Jonathan WangVerified
Private Equity Firm · China
Health CareLife ScienceInformation Technology (IT)MobilePortfolio: Edgewise Therapeutics, Syros Pharmaceuticals, Yisheng Biopharma, Evox Therapeutics and 87 more
Verified email available
Rishi GuptaVerified
Private Equity Firm · United States
Health CareInvestment ManagementLife ScienceInformation Technology (IT)Portfolio: Edgewise Therapeutics, Syros Pharmaceuticals, Yisheng Biopharma, Evox Therapeutics and 87 more
Verified email available
Ron HuntVerified
Venture Capital, Private Equity Firm · United States
Health CareCybersecurityMessagingWomen FoundedPortfolio: iRhythm Technologies, Braeburn, Direct Flow Medical, Edgewise Therapeutics and 56 more
Verified email available
Todd BradyVerified
Venture Capital, Private Equity Firm · United States
Health CareGeneticsWomen FoundedLife SciencePortfolio: F2G, UNUM Therapeutics, Avidity Biosciences, Avrobio and 10 more
Contact details available
Alexandre Foulon
Venture Capital, Private Equity Firm, Investor · France
Series BHealth CareWearablesHospitalsDeepTechPortfolio: Genoa Pharmaceuticals, ENYO Pharma, OncoEthix, AM Pharma and 79 more
Contact details available
Arnaud Faure
Venture Capital, Private Equity Firm, Investor · France
Series BHealth CareWearablesHospitalsWellnessPortfolio: Genoa Pharmaceuticals, ENYO Pharma, OncoEthix, AM Pharma and 79 more
Contact details available
Carter Neild
Venture Capital, Private Equity Firm, Investor · United States
SeedSeries AHealth CareInvestment ManagementLife ScienceInformation Technology (IT)Portfolio: Edgewise Therapeutics, Syros Pharmaceuticals, Yisheng Biopharma, Evox Therapeutics and 87 more
Contact details available
Chau Khuong
Venture Capital, Private Equity Firm, Investor · United States
SeedSeries AHealth CareLife ScienceInformation Technology (IT)MobilePortfolio: Edgewise Therapeutics, Syros Pharmaceuticals, Gennao Bio, Yisheng Biopharma and 89 more
Contact details available
Mayeul Caron
Venture Capital, Private Equity Firm, Investor · France
Series BHealth CareWearablesHospitalsWellnessPortfolio: Genoa Pharmaceuticals, ENYO Pharma, OncoEthix, AM Pharma and 79 more
Contact details available
Pierre
Venture Capital, Private Equity Firm, Investor · France
Series BHealth CareWearablesHospitalsWellnessPortfolio: Genoa Pharmaceuticals, ENYO Pharma, OncoEthix, AM Pharma and 79 more
Contact details available
Scotland Stevens
Venture Capital, Private Equity Firm, Investor · United States
SeedSeries AHealth CareInvestment ManagementLife ScienceInformation Technology (IT)Portfolio: Edgewise Therapeutics, Syros Pharmaceuticals, Yisheng Biopharma, Evox Therapeutics and 87 more
Contact details available
Anat Naschitz
Private Equity Firm · Israel
Health CareLife ScienceInformation Technology (IT)MobilePortfolio: Edgewise Therapeutics, Syros Pharmaceuticals, Yisheng Biopharma, Evox Therapeutics and 87 more
Contact details available
Craig Slutzkin
Venture Capital, Private Equity Firm · United States
Health CareCybersecurityMessagingWomen FoundedPortfolio: iRhythm Technologies, Braeburn, Direct Flow Medical, Edgewise Therapeutics and 56 more
Contact details available
David Robin
Venture Capital, Private Equity Firm · France
Health CareWearablesHospitalsWellnessPortfolio: Genoa Pharmaceuticals, ENYO Pharma, OncoEthix, AM Pharma and 79 more
Contact details available
Erez Chimovits
Private Equity Firm · Israel
Health CareInvestment ManagementLife ScienceInformation Technology (IT)Portfolio: Edgewise Therapeutics, Syros Pharmaceuticals, Yisheng Biopharma, Evox Therapeutics and 87 more
Contact details available
James Niedel
Venture Capital, Private Equity Firm · United States
Health CareCybersecurityMessagingWomen FoundedPortfolio: iRhythm Technologies, Braeburn, Direct Flow Medical, Edgewise Therapeutics and 56 more
Contact details available
Jeffrey Ives
Venture Capital · United States
Health CareCybersecurityMessagingWomen FoundedPortfolio: iRhythm Technologies, Braeburn, Direct Flow Medical, Edgewise Therapeutics and 56 more
Contact details available
Pierre Morisseau
Venture Capital, Private Equity Firm · France
Health CareWearablesHospitalsWellnessPortfolio: Genoa Pharmaceuticals, ENYO Pharma, OncoEthix, AM Pharma and 79 more
Contact details available
Rebecca Luse
Venture Capital · United States
Health CareCybersecurityMessagingWomen FoundedPortfolio: iRhythm Technologies, Braeburn, Direct Flow Medical, Edgewise Therapeutics and 56 more
Contact details available
Vijay Lathi
Venture Capital, Private Equity Firm · United States
Health CareCybersecurityMessagingWomen FoundedPortfolio: iRhythm Technologies, Braeburn, Direct Flow Medical, Edgewise Therapeutics and 56 more
Contact details available
Raphael Wisniewski
Venture Capital, Investor · France
Series BElectronic Health Records (EHR)Health and Hospital ServicesDigital HealthMedicalPortfolio: ReViral, Exciva, Vessix Vascular
Contact details available
By investment stage
By location
Related industries
Most-backed portfolio companies
- Verona Pharma17
- UNUM Therapeutics17
- Passage Bio16
- Edgewise Therapeutics16
- Decibel Therapeutics10
- Cleave Therapeutics10
- Nucleix10
- Keros Therapeutics10
- Caris Life Sciences10
- Adagio Therapeutics10
- AnchorDx10
Frequently asked questions
How many ReViral investors are on Angel Roster?
Angel Roster lists 25 ReViral investors. 7 of them (28%) include a verified email address.
What types of investors are they?
The most common investor types are Private Equity Firms (22) and Venture Capital Firms (20). An investor can have more than one type, for example an angel who is also a venture partner.
Which stages do ReViral investors invest in?
Among those that list a stage, the most common are Series B (6), Seed (5) and Series A (5).
Where are ReViral investors based?
Most are based in the United States (14), France (7) and Israel (2).
Which companies have ReViral investors backed?
The most-backed portfolio companies among them are Verona Pharma (17), UNUM Therapeutics (17), Passage Bio (16), Edgewise Therapeutics (16) and Decibel Therapeutics (10).
How do I contact ReViral investors?
Create a free Angel Roster account to search and filter all 25, then unlock verified emails and LinkedIn profiles on a paid plan. Every plan starts with a 3-day free trial.